vs
iRhythm Holdings, Inc.（IRTC）与Penumbra Inc（PEN）财务数据对比。点击上方公司名可切换其他公司
Penumbra Inc的季度营收约是iRhythm Holdings, Inc.的1.8倍（$385.4M vs $208.9M）。Penumbra Inc净利率更高（12.3% vs 2.7%，领先9.6%）。iRhythm Holdings, Inc.同比增速更快（27.1% vs 22.1%）。Penumbra Inc自由现金流更多（$68.0M vs $14.5M）。过去两年iRhythm Holdings, Inc.的营收复合增速更高（25.8% vs 17.6%）
iRhythm Holdings是一家专注于心脏护理领域的数字医疗企业，开发可穿戴动态心脏监测设备及配套AI分析工具，主要服务美国市场的医疗机构与患者，帮助检测房颤等心律异常病症，为临床诊断提供可靠的数据支持。
Penumbra Inc是2004年由Arani Bose与Adam Elsesser联合创立的美国医疗器械企业，总部位于加利福尼亚州阿拉米达，核心业务为研发、生产中风、动脉瘤等血管疾病介入治疗所用的专业医疗设备，产品已在全球多个国家的临床诊疗场景中投入使用。
IRTC vs PEN — 直观对比
营收规模更大
PEN
是对方的1.8倍
$208.9M
营收增速更快
IRTC
高出5.0%
22.1%
净利率更高
PEN
高出9.6%
2.7%
自由现金流更多
PEN
多$53.6M
$14.5M
两年增速更快
IRTC
近两年复合增速
17.6%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $208.9M | $385.4M |
| 净利润 | $5.6M | $47.3M |
| 毛利率 | 70.9% | 68.0% |
| 营业利润率 | 1.1% | 15.4% |
| 净利率 | 2.7% | 12.3% |
| 营收同比 | 27.1% | 22.1% |
| 净利润同比 | 518.5% | 40.6% |
| 每股收益（稀释后） | $0.18 | $1.20 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收IRTCPEN
| Q4 25 | $208.9M | $385.4M | ||
| Q3 25 | $192.9M | $354.7M | ||
| Q2 25 | $186.7M | $339.5M | ||
| Q1 25 | $158.7M | $324.1M | ||
| Q4 24 | $164.3M | $315.5M | ||
| Q3 24 | $147.5M | $301.0M | ||
| Q2 24 | $148.0M | $299.4M | ||
| Q1 24 | $131.9M | $278.7M |
净利润IRTCPEN
| Q4 25 | $5.6M | $47.3M | ||
| Q3 25 | $-5.2M | $45.9M | ||
| Q2 25 | $-14.2M | $45.3M | ||
| Q1 25 | $-30.7M | $39.2M | ||
| Q4 24 | $-1.3M | $33.7M | ||
| Q3 24 | $-46.2M | $29.5M | ||
| Q2 24 | $-20.1M | $-60.2M | ||
| Q1 24 | $-45.7M | $11.0M |
毛利率IRTCPEN
| Q4 25 | 70.9% | 68.0% | ||
| Q3 25 | 71.1% | 67.8% | ||
| Q2 25 | 71.2% | 66.0% | ||
| Q1 25 | 68.8% | 66.6% | ||
| Q4 24 | 70.0% | 66.8% | ||
| Q3 24 | 68.8% | 66.5% | ||
| Q2 24 | 69.9% | 54.4% | ||
| Q1 24 | 66.3% | 65.0% |
营业利润率IRTCPEN
| Q4 25 | 1.1% | 15.4% | ||
| Q3 25 | -4.4% | 13.8% | ||
| Q2 25 | -10.0% | 12.0% | ||
| Q1 25 | -20.5% | 12.4% | ||
| Q4 24 | -2.5% | 13.6% | ||
| Q3 24 | -34.1% | 11.7% | ||
| Q2 24 | -15.5% | -27.0% | ||
| Q1 24 | -28.9% | 4.3% |
净利率IRTCPEN
| Q4 25 | 2.7% | 12.3% | ||
| Q3 25 | -2.7% | 12.9% | ||
| Q2 25 | -7.6% | 13.3% | ||
| Q1 25 | -19.3% | 12.1% | ||
| Q4 24 | -0.8% | 10.7% | ||
| Q3 24 | -31.3% | 9.8% | ||
| Q2 24 | -13.6% | -20.1% | ||
| Q1 24 | -34.6% | 3.9% |
每股收益（稀释后）IRTCPEN
| Q4 25 | $0.18 | $1.20 | ||
| Q3 25 | $-0.16 | $1.17 | ||
| Q2 25 | $-0.44 | $1.15 | ||
| Q1 25 | $-0.97 | $1.00 | ||
| Q4 24 | $-0.03 | $0.88 | ||
| Q3 24 | $-1.48 | $0.75 | ||
| Q2 24 | $-0.65 | $-1.55 | ||
| Q1 24 | $-1.47 | $0.28 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $583.8M | $186.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $152.7M | $1.4B |
| 总资产 | $1.0B | $1.8B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资IRTCPEN
| Q4 25 | $583.8M | $186.9M | ||
| Q3 25 | $565.2M | $321.0M | ||
| Q2 25 | $545.5M | $421.8M | ||
| Q1 25 | $520.6M | $376.1M | ||
| Q4 24 | $535.6M | $324.4M | ||
| Q3 24 | $522.0M | $280.5M | ||
| Q2 24 | $561.5M | $288.3M | ||
| Q1 24 | $569.1M | $223.1M |
股东权益IRTCPEN
| Q4 25 | $152.7M | $1.4B | ||
| Q3 25 | $121.9M | $1.4B | ||
| Q2 25 | $103.7M | $1.3B | ||
| Q1 25 | $86.7M | $1.2B | ||
| Q4 24 | $90.9M | $1.2B | ||
| Q3 24 | $71.8M | $1.1B | ||
| Q2 24 | $99.2M | $1.2B | ||
| Q1 24 | $90.3M | $1.2B |
总资产IRTCPEN
| Q4 25 | $1.0B | $1.8B | ||
| Q3 25 | $995.2M | $1.7B | ||
| Q2 25 | $964.0M | $1.7B | ||
| Q1 25 | $926.1M | $1.6B | ||
| Q4 24 | $931.4M | $1.5B | ||
| Q3 24 | $909.7M | $1.5B | ||
| Q2 24 | $919.2M | $1.5B | ||
| Q1 24 | $909.8M | $1.6B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $26.2M | $86.5M |
| 自由现金流经营现金流 - 资本支出 | $14.5M | $68.0M |
| 自由现金流率自由现金流/营收 | 6.9% | 17.7% |
| 资本支出强度资本支出/营收 | 5.6% | 4.8% |
| 现金转化率经营现金流/净利润 | 4.70× | 1.83× |
| 过去12个月自由现金流最近4个季度 | $34.5M | $174.9M |
8季度趋势，按日历期对齐
经营现金流IRTCPEN
| Q4 25 | $26.2M | $86.5M | ||
| Q3 25 | $34.9M | $58.3M | ||
| Q2 25 | $27.7M | $44.9M | ||
| Q1 25 | $-7.9M | $49.0M | ||
| Q4 24 | $19.2M | $51.1M | ||
| Q3 24 | $24.3M | $56.5M | ||
| Q2 24 | $11.8M | $22.6M | ||
| Q1 24 | $-52.0M | $38.3M |
自由现金流IRTCPEN
| Q4 25 | $14.5M | $68.0M | ||
| Q3 25 | $20.1M | $42.0M | ||
| Q2 25 | $17.3M | $29.4M | ||
| Q1 25 | $-17.3M | $35.5M | ||
| Q4 24 | $12.4M | $45.7M | ||
| Q3 24 | $15.5M | $51.0M | ||
| Q2 24 | $3.4M | $18.1M | ||
| Q1 24 | $-61.8M | $32.5M |
自由现金流率IRTCPEN
| Q4 25 | 6.9% | 17.7% | ||
| Q3 25 | 10.4% | 11.8% | ||
| Q2 25 | 9.3% | 8.7% | ||
| Q1 25 | -10.9% | 11.0% | ||
| Q4 24 | 7.5% | 14.5% | ||
| Q3 24 | 10.5% | 16.9% | ||
| Q2 24 | 2.3% | 6.0% | ||
| Q1 24 | -46.8% | 11.7% |
资本支出强度IRTCPEN
| Q4 25 | 5.6% | 4.8% | ||
| Q3 25 | 7.7% | 4.6% | ||
| Q2 25 | 5.6% | 4.6% | ||
| Q1 25 | 5.9% | 4.2% | ||
| Q4 24 | 4.2% | 1.7% | ||
| Q3 24 | 6.0% | 1.8% | ||
| Q2 24 | 5.7% | 1.5% | ||
| Q1 24 | 7.4% | 2.1% |
现金转化率IRTCPEN
| Q4 25 | 4.70× | 1.83× | ||
| Q3 25 | — | 1.27× | ||
| Q2 25 | — | 0.99× | ||
| Q1 25 | — | 1.25× | ||
| Q4 24 | — | 1.52× | ||
| Q3 24 | — | 1.91× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 3.48× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
IRTC
| Commercial Payors | $111.7M | 53% |
| Centers For Medicare And Medicaid | $49.2M | 24% |
| Healthcare Institutions | $34.3M | 16% |
| Non Contracted Third Party Payors | $13.7M | 7% |
PEN
暂无分部数据
